1047 related articles for article (PubMed ID: 10548883)
21. The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution.
Jones SA; Moore LB; Shenk JL; Wisely GB; Hamilton GA; McKee DD; Tomkinson NC; LeCluyse EL; Lambert MH; Willson TM; Kliewer SA; Moore JT
Mol Endocrinol; 2000 Jan; 14(1):27-39. PubMed ID: 10628745
[TBL] [Abstract][Full Text] [Related]
22. Induction of phase I, II and III drug metabolism/transport by xenobiotics.
Xu C; Li CY; Kong AN
Arch Pharm Res; 2005 Mar; 28(3):249-68. PubMed ID: 15832810
[TBL] [Abstract][Full Text] [Related]
23. Regulation of cyp3a gene transcription by the pregnane x receptor.
Goodwin B; Redinbo MR; Kliewer SA
Annu Rev Pharmacol Toxicol; 2002; 42():1-23. PubMed ID: 11807162
[TBL] [Abstract][Full Text] [Related]
24. Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors.
Moore LB; Maglich JM; McKee DD; Wisely B; Willson TM; Kliewer SA; Lambert MH; Moore JT
Mol Endocrinol; 2002 May; 16(5):977-86. PubMed ID: 11981033
[TBL] [Abstract][Full Text] [Related]
25. [The role of nuclear receptors in cytochrome P-450 induction by xenochemicals].
Palut D; Kostka G; Struciński P
Rocz Panstw Zakl Hig; 2002; 53(4):321-32. PubMed ID: 12664659
[TBL] [Abstract][Full Text] [Related]
26. Conservation of signaling pathways of xenobiotic-sensing orphan nuclear receptors, chicken xenobiotic receptor, constitutive androstane receptor, and pregnane X receptor, from birds to humans.
Handschin C; Podvinec M; Stöckli J; Hoffmann K; Meyer UA
Mol Endocrinol; 2001 Sep; 15(9):1571-85. PubMed ID: 11518807
[TBL] [Abstract][Full Text] [Related]
27. The xenobiotic-sensing nuclear receptors pregnane X receptor, constitutive androstane receptor, and orphan nuclear receptor hepatocyte nuclear factor 4alpha in the regulation of human steroid-/bile acid-sulfotransferase.
Echchgadda I; Song CS; Oh T; Ahmed M; De La Cruz IJ; Chatterjee B
Mol Endocrinol; 2007 Sep; 21(9):2099-111. PubMed ID: 17595319
[TBL] [Abstract][Full Text] [Related]
28. Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects.
di Masi A; De Marinis E; Ascenzi P; Marino M
Mol Aspects Med; 2009 Oct; 30(5):297-343. PubMed ID: 19427329
[TBL] [Abstract][Full Text] [Related]
29. PPAR: a mediator of peroxisome proliferator action.
Green S
Mutat Res; 1995 Dec; 333(1-2):101-9. PubMed ID: 8538617
[TBL] [Abstract][Full Text] [Related]
30. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay.
Krey G; Braissant O; L'Horset F; Kalkhoven E; Perroud M; Parker MG; Wahli W
Mol Endocrinol; 1997 Jun; 11(6):779-91. PubMed ID: 9171241
[TBL] [Abstract][Full Text] [Related]
31. Activators of the nuclear receptor PPARgamma enhance colon polyp formation.
Saez E; Tontonoz P; Nelson MC; Alvarez JG; Ming UT; Baird SM; Thomazy VA; Evans RM
Nat Med; 1998 Sep; 4(9):1058-61. PubMed ID: 9734400
[TBL] [Abstract][Full Text] [Related]
32. Role of metabolism in the activation of dehydroepiandrosterone as a peroxisome proliferator.
Waxman DJ
J Endocrinol; 1996 Sep; 150 Suppl():S129-47. PubMed ID: 8943797
[TBL] [Abstract][Full Text] [Related]
33. Peroxisome proliferator-activated receptors in the cardiovascular system.
Bishop-Bailey D
Br J Pharmacol; 2000 Mar; 129(5):823-34. PubMed ID: 10696077
[TBL] [Abstract][Full Text] [Related]
34. The effects of cytochrome P450 induction by xenobiotics on endobiotic metabolism in pre-clinical safety studies.
Amacher DE
Toxicol Mech Methods; 2010 May; 20(4):159-66. PubMed ID: 20218941
[TBL] [Abstract][Full Text] [Related]
35. Fatty acids and immune responses--a new perspective in searching for clues to mechanism.
Hwang D
Annu Rev Nutr; 2000; 20():431-56. PubMed ID: 10940341
[TBL] [Abstract][Full Text] [Related]
36. Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology.
Lemberger T; Desvergne B; Wahli W
Annu Rev Cell Dev Biol; 1996; 12():335-63. PubMed ID: 8970730
[TBL] [Abstract][Full Text] [Related]
37. Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor alpha.
Murakami K; Ide T; Suzuki M; Mochizuki T; Kadowaki T
Biochem Biophys Res Commun; 1999 Jul; 260(3):609-13. PubMed ID: 10403814
[TBL] [Abstract][Full Text] [Related]
38. Ligand selectivity of the peroxisome proliferator-activated receptor alpha.
Lin Q; Ruuska SE; Shaw NS; Dong D; Noy N
Biochemistry; 1999 Jan; 38(1):185-90. PubMed ID: 9890897
[TBL] [Abstract][Full Text] [Related]
39. Nuclear receptors and nonalcoholic fatty liver disease.
Cave MC; Clair HB; Hardesty JE; Falkner KC; Feng W; Clark BJ; Sidey J; Shi H; Aqel BA; McClain CJ; Prough RA
Biochim Biophys Acta; 2016 Sep; 1859(9):1083-1099. PubMed ID: 26962021
[TBL] [Abstract][Full Text] [Related]
40. Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators.
Corton JC; Anderson SP; Stauber A
Annu Rev Pharmacol Toxicol; 2000; 40():491-518. PubMed ID: 10836145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
